# Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection

> **NCT05672498** · NA · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 100 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Traditional Chinese Medicine Formulation
- **OTHER:** Placebo Treatment

## Key facts

- **NCT ID:** NCT05672498
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-05
- **Primary completion:** 2023-04-05
- **Final completion:** 2023-05-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05672498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05672498, "Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05672498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
